Results 141 to 150 of about 1,353,338 (294)

Improving PARP inhibitor efficacy in bladder cancer without genetic BRCAness by combination with PLX51107

open access: yesMolecular Oncology, EarlyView.
Clinical trials on PARP inhibitors in urothelial carcinoma (UC) showed limited efficacy and a lack of predictive biomarkers. We propose SLFN5, SLFN11, and OAS1 as UC‐specific response predictors. We suggest Talazoparib as the better PARP inhibitor for UC than Olaparib.
Jutta Schmitz   +15 more
wiley   +1 more source

Retracted: An Improved Deep Belief Network IDS on IoT-Based Network for Traffic Systems

open access: yesJournal of Advanced Transportation, 2023
Journal of Advanced Transportation
doaj   +1 more source

Cytoplasmic p21 promotes stemness of colon cancer cells via activation of the NFκB pathway

open access: yesMolecular Oncology, EarlyView.
Cytoplasmic p21 promotes colorectal cancer stem cell (CSC) features by destabilizing the NFκB–IκB complex, activating NFκB signaling, and upregulating BCL‐xL and COX2. In contrast to nuclear p21, cytoplasmic p21 enhances spheroid formation and stemness transcription factor CD133.
Arnatchai Maiuthed   +10 more
wiley   +1 more source

Retracted: A Way to Automatically Generate Lane Level Traffic Data from Video in the Intersections

open access: yesJournal of Advanced Transportation, 2023
Journal of Advanced Transportation
doaj   +1 more source

In Memoriam - Academician Josip Božičević (1929-1921)

open access: yesPromet (Zagreb), 2021
Editorial Board Promet – Traffic&Transportation
doaj   +1 more source

Home - About - Disclaimer - Privacy